#1
17th August 2017, 11:16 AM
| |||
| |||
IRDA Underwriting
Is there anybody who will provide Underwriting guidelines for PLHA of IRDA? My father wants Underwriting guidelines for PLHA of IRDA, so do you know from where he can get this Guideline?
|
#2
17th August 2017, 11:43 AM
| |||
| |||
Re: IRDA Underwriting
As you are looking for Underwriting guidelines for PLHA of IRDA, so I am providing complete Guidelines here: IRDA Underwriting guidelines for PLHA a) LIFE Insurance plan only. b) No niche Product will be developed. Base pricing of the insurance company can vary (as with current products), but the extra mortality charges and underwriting guidelines for PLHA across the companies will remain the same. c) Product Guidelines: Plan: Life Insurance Plans including Term Plans (Satisfying below product criteria). Minimum Entry: 25 years Maximum Entry: 45 Years Minimum term: 5 years Maximum term: 15 years subject to below outlined criteria Maximum maturity age: 55 years Maximum Sum assured (from all companies) Regular Premium: INR 1,000,000 Single Premium : INR 2,000,000 d) Underwriting Guidelines: Life insured should be EITHER registered with government approved ART nodal agency for a consecutive period of preceding 2 years from the date of application OR if the treatment is taken from a Private hospital, detailed records of treatment and medical history for a consecutive period of preceding 2 yrs to be sent directly by the treating hospital/physician to the insurance company CMO. Duration of Cover: If on ART Treatment (copy of treatment record to be submitted (attached below)): < 2 yrs on ART: defer risk till end of Year 2 of treatment Treatment into Year 3 to end of Year 5: Maximum term 15 years Treatment into Year 6 to end of Year 8: Maximum term 10 years Treatment into Year 9 to end of Year 10: Maximum term 5 years No major systemic (e.g. renal/hepatic/cardiac) side effects of treatment should be present If no ART treatment is required, and the applicant is asymptomatic for: < 1 year since date of diagnosis of HIV/AIDS: defer risk > 1 year since diagnosis of HIV/AIDS: maximum term 10 years subject to CD4 count/viral load over 1 year period HIV/AIDS Caused due to Intravenous Drug Use: Decline HIV/AIDS Stages to be covered: Offer cover up to Stage II only (as defined by WHO in the current guidelines) To get complete information, download the attachment |